Coherus BioSciences Inc (NASDAQ:CHRS)
| 7.64 Delayed Data As of 4:00pm ET |  +0.23 / +3.10%Today’s Change | 7.24 Today|||52-Week Range 19.32 | -52.13% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 30.0M | 190.1M | 1.6M | 0.00 | |
| Depreciation And Amortization | 1.9M | 3.0M | 3.4M | 3.2M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -3.2M | |
| General Expenses | 246.9M | 303.0M | 226.1M | 197.3M | ||
| Research And Development | 212.7M | 254.4M | 160.5M | 106.4M | ||
| Total Operating Expenses | 248.7M | 306.0M | 229.5M | 200.6M | ||
| Non-Operating Expenses | Operating Income | -218.7M | -115.9M | -228.0M | -200.6M | |
| Extraordinary Credit | 0.00 | 0.00 | 2.3M | 3.2M | ||
| Extraordinary Charge | -5.0M | -4.3M | -4.2M | -3.9M | ||
| Interest Expense On Debt | 33.0K | 8.0M | 9.6M | 9.7M | ||
| Other Expenses | -239.0K | 428.0K | 1.1M | 1.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -223.9M | -127.8M | -238.3M | -209.4M | |
| Minority Interest | -678.0K | -451.0K | -116.0K | -70.0K | ||
| Net Income | -223.3M | -127.3M | -238.2M | -209.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 37.1M | 41.9M | 53.1M | 65.0M | |
| Shares To Calculate EPS Diluted | 37.1M | 41.9M | 53.1M | 65.0M | ||
| Earnings Per Share | EPS | -$6.01 | -$3.04 | -$4.48 | -$3.22 | |
| EPS Diluted | -$6.01 | -$3.04 | -$4.48 | -$3.22 | ||
